by Jason Heaviland | Jul 23, 2026
How Genomics and Exposomics Will Transform Precision Medicine Genomics has transformed precision medicine by revealing an individual’s genetic blueprint—but genetics alone cannot explain why people with similar genomes often experience very different health...
by Jason Heaviland | Jul 22, 2026
How Exposomics Can Improve Clinical Trials and Precision Medicine Why do promising drugs fail in Phase III clinical trials? Why do patients respond differently to the same therapy across countries? And if genetics only explains part of disease risk, what information...
by Jason Heaviland | Jul 16, 2026
How are exposure patterns linked to biological pathways? Environmental chemical exposures can significantly influence drug metabolism, therapeutic response, and disease biology—but they are often overlooked in biomedical research and clinical development.In this...
by Jason Heaviland | Jun 12, 2026
ChatGJP: Discovery vs Targeted Exposomics Explained Should you use discovery exposomics or targeted exposomics? In this episode of ChatGJP, Panome Bio CEO Ed Weinstein explains the strengths of each approach and how they work together to provide a comprehensive...
by Jason Heaviland | Jun 2, 2026
ChatGJP: Exposomics, PFAS, and Clinical Trial Implications In this episode of ChatGJP, Panome Bio President and Co-Founder Tom Cohen explores the growing field of exposomics and its role in understanding how environmental exposures influence human health and disease....
